Michael Pine

Michael Pine is a seasoned business leader with over 20 years of diverse experience in the pharmaceutical industry, having worked in small, medium, and large companies.

He has developed a comprehensive C-Suite skill set encompassing Strategy, Leadership, BD&L Negotiations, M&A, Product Marketing, Operations, and more, backed by a B.S. from Cornell and an MBA from Columbia Business School.

Throughout his career at companies like Chase, Wyeth, Pfizer, Organon, Novartis, Aralez, and Lupin, Michael has been involved in high-level strategic decision-making, deal structuring, team management, and creating significant value through transformational deals.

His areas of expertise include negotiations, strategic thinking, financial analysis, problem-solving, and networking, with a proven track record of assessing opportunities and challenges to drive business growth.

Michael Pine's educational background includes an MBA focused on Strategy, Marketing, Management, and Finance from Columbia Business School, and a BS in Economics, Pre-med, and Marketing from Cornell University.

Currently serving as the Senior Vice President of Business Development & Strategy at Medexus Pharmaceuticals, Inc., Michael has previously held strategic roles at Lupin Pharmaceuticals, Aralez Pharmaceuticals, Novartis, Kos Pharmaceuticals, Organon Pharmaceuticals, Pfizer, and JP Morgan Chase.

He has a reputation for utilizing his deep industry knowledge, negotiation skills, and ability to evaluate opportunities to make impactful business decisions and navigate the complexities of the pharmaceutical landscape while also actively contributing to industry events and supporting others in achieving their objectives.